The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*-Reference-Cited by-同舟云学术

The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*

Published:2014-07 Issue:7 Volume:42 Page:e525-e533
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Maybauer Marc O.,Maybauer Dirk M.,Enkhbaatar Perenlei,Laporte Régent,Wiśniewska Halina,Traber Lillian D.,Lin ChiiDean,Fan Juanjuan,Hawkins Hal K.,Cox Robert A.,Wiśniewski Kazimierz,Schteingart Claudio D.,Landry Donald W.,Rivière Pierre J.-M.,Traber Daniel L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference48 articles.

1. Epidemiology of Severe Sepsis Around the World

2. Long-term outcomes from sepsis

3. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis

4. Implementation of early goal-directed therapy for severe sepsis and septic shock: A decision analysis

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges;Molecular Therapy - Nucleic Acids;2024-06

2. Target-Based Screening for Lead Discovery;Interdisciplinary Biotechnological Advances;2023

3. Vasopressin;Small Animal Critical Care Medicine;2023

4. Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats;Scientific Reports;2022-11-28

5. S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases;Molecules;2022-10-06